Pulmonology

The first-of-its-kind research links inhaled corticosteroids to adrenal suppression in asthma and chronic obstructive pulmonary disease patients who have a genetic variant in the PDGFD gene.

A Phase 2a clinical study evaluating Molgradex was recently initiated by Savara, Inc. The study intends to evaluate the reduction of sputum samples without growth of non-tuberculosis mycobacteria during the treatment period.

The survey estimates from the National Center for Health Statistics report that more people are vaccinating for flu and testing for HIV.

The therapy was approved on the evidence of a pivotal phase 3 clinical development program which tested the efficacy of the inhibitor versus placebo in 926 adult patients.

Many studies have already shown that short-term exposure to fine particle pollution can have a negative effect on lung function, but just 2 exist on the long-term effects, with inconsistent results.

The U.S. FDA granted Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease (SSc-ILD).

The anti-inflammatory proved superior to as-need bronchodilator for control of early stage asthma symptoms in preschool children.

Psychological stress-induced alterations of the neuroendocrine-immune system in allergic airway inflammation suggest a novel phenotype in asthma.

New research indicates overweight patients may have worse asthma control outcomes after a year of subcutaneous immunotherapy than their normal weight counterparts.

This morning, Alynylam Pharmaceuticals, Inc. has announced the Bridge the Gap initiative in which it will partner with a family affected by hATTR amyloidosis for a new book. The initiative, called , will allow the family that has lived with the rare disease for generations to share its personal accounts. The book is titled “Living a Rare Life,” and can be found, along with other educational content, at hATTRBridge.com.

While some studies have shown that steroids helped resolve sore throats faster, others have indicated that steroids show no effectiveness for sinusitis or bronchitis.